Kunal Shah

Kunal Shah is an experienced professional in the healthcare industry with a robust background in business development and product management. Currently engaged in healthcare investing at Yosemite and business development at Psivant Therapeutics, Kunal has previously held roles in business development at Seismic Therapeutic and product leadership at Valar Labs, focusing on AI and digital pathology for oncology biomarkers. Kunal's earlier experience includes product management at Foundation Medicine and business analysis at McKinsey & Company. Academic qualifications include a BA in Biological Sciences from Columbia University and an MBA in Healthcare Management from The Wharton School.